Insider · CIK 0001356227

RIGBY JONATHAN

Reports to the SEC for 5 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001356227

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-01	ONCYONCOLYTICS BIOTECH INC · Stock OptionA Award	Director	AAward	+30K sh	—	—	30,000
2019-02-27	XERIS PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2018-08-30	SteadyMed Ltd.Stock Option (Rt to Buy)J Other	Director, President and CEO	JOther	−131K sh	—	—	0
2018-08-30	SteadyMed Ltd.S Sale	Director, President and CEO	SSale	−41.6K sh	$4.46	−$186K	0
2018-08-30	SteadyMed Ltd.S Sale	Director, President and CEO	SSale	−4,960 sh	$4.46	−$22.1K	0
2018-08-30	SteadyMed Ltd.Stock Option (Rt to Buy)J Other	Director, President and CEO	JOther	−18.5K sh	—	—	0
2018-08-30	SteadyMed Ltd.Stock Option (Rt to Buy)J Other	Director, President and CEO	JOther	−145K sh	—	—	0
2018-08-30	SteadyMed Ltd.Stock Option (Rt to Buy)J Other	Director, President and CEO	JOther	−63.8K sh	—	—	0
2018-08-30	SteadyMed Ltd.Stock Option (Rt to Buy)J Other	Director, President and CEO	JOther	−163K sh	—	—	0
2018-08-24	SteadyMed Ltd.S Sale	Director, President and CEO	SSale	−17K sh	$4.70	−$79.9K	41,605
2018-08-24	SteadyMed Ltd.Stock Options (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−17K sh	—	—	22,097
2018-08-24	SteadyMed Ltd.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+17K sh	$2.74	+$46.6K	58,599
2018-08-23	SteadyMed Ltd.S Sale	Director, President and CEO	SSale	−44.2K sh	$4.73	−$209K	41,605
2018-08-23	SteadyMed Ltd.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+44.2K sh	$2.74	+$121K	85,847
2018-08-23	SteadyMed Ltd.Stock Options (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−44.2K sh	—	—	39,091
2018-08-17	SteadyMed Ltd.S Sale	Director, President and CEO	SSale	−88.8K sh	$4.66	−$414K	41,605
2018-08-09	SteadyMed Ltd.Stock Option (Rt to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−88.8K sh	—	—	0
2018-08-09	SteadyMed Ltd.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+88.8K sh	$3.61	+$321K	130,436
2018-07-02	SteadyMed Ltd.S Sale	Director, President and CEO	SSale	−4,961 sh	$4.50	−$22.3K	4,960
2018-07-02	SteadyMed Ltd.S Sale	Director, President and CEO	SSale	−41.6K sh	$4.50	−$187K	41,605
2017-12-28	SteadyMed Ltd.A Award	Director, President and CEO	AAward	+83.2K sh	—	—	83,210
2017-12-28	SteadyMed Ltd.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+163K sh	—	—	163,394
2016-06-17	SteadyMed Ltd.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+125K sh	—	—	125,000

Recent filings

Accepted (ET)
Jun 34
RIGBY JONATHAN0001493152-26-027097
SEC(opens sec.gov)
Mar 14
RIGBY JONATHAN0000899243-19-005457
SEC(opens sec.gov)
Sep 44
RIGBY JONATHAN0001209191-18-049375
SEC(opens sec.gov)
Aug 274
RIGBY JONATHAN0001562180-18-003770
SEC(opens sec.gov)
Aug 174
RIGBY JONATHAN0001562180-18-003675
SEC(opens sec.gov)
Aug 104
RIGBY JONATHAN0001209191-18-046227
SEC(opens sec.gov)
Jul 34
RIGBY JONATHAN0001104659-18-043808
SEC(opens sec.gov)

Companies

Address

C/O ONCOLYTICS BIOTECH INC. 4350 EXECUTIVE DRIVE, SUITE 325

SAN DIEGO, CA, 92121